SAPPORO CLINICAL LABORATORY INC., First Half Ordinary Profit Increases by 16%, July-September Ordinary Profit Increases by 12%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Nov 8, 2024 3:30 pm JST Earnings

9776 SAPPORO CLINICAL LABORATORY INC. 【J-GAAP】

Earnings Report

SAPPORO CLINICAL LABORATORY INC. <9776> [TSE-S] announced its financial results after the market closed on November 8th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) increased by 15.9% from the same period last year, reaching 343 million yen. The progress rate against the 493 million yen full-year plan was 69.6%, also surpassing the five-year average of 48.6%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to drop by 31.2% from the same period last year to 150 million yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit grew by 11.6% from the same period last year, reaching 241 million yen. The operating profit margin improved from 4.4% in the same period last year to 4.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	9,964	492	589	258	77.4	50.8	Nov 9, 2022	J-GAAP
Apr - Sep, 2023	9,862	291	296	226	67.9	57.6	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	9,996	337	343	222	70.9	69.6	Nov 8, 2024	J-GAAP
YoY	+1.4%	+15.8%	+15.9%	-1.8%	+4.3%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	9,996	337	343	222	71.2	0	Nov 1, 2024	J-GAAP
Apr - Sep, 2024 Results	9,996	337	343	222	70.9	0	Nov 8, 2024	J-GAAP
Revision Rate	0.0%	0.0%	0.0%	0.0%	-0.4%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	9,820	243	218	154	46.3	23	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	9,803	163	150	98	31.4	23	Nov 1, 2024	J-GAAP
YoY	-0.2%	-32.9%	-31.2%	-36.4%	-32.1%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	20,127	1,008	1,159	568	170.5	23	May 12, 2023	J-GAAP
Mar, 2024	19,682	534	514	380	114.1	23	May 13, 2024	J-GAAP
Mar, 2025 Guidance	19,799	500	493	320	102.6	23	May 13, 2024	J-GAAP
YoY	+0.6%	-6.4%	-4.1%	-15.8%	-10.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	4,940	216	216	221	66.4	4.4	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	4,990	123	121	85	25.6	2.5	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	4,830	120	97	69	20.7	2.5	May 13, 2024	J-GAAP
Apr - Jun, 2024	4,999	98	102	56	17.9	2.0	Aug 5, 2024	J-GAAP
Jul - Sep, 2024	4,997	239	241	166	53.0	4.8	Nov 8, 2024	J-GAAP
YoY	+1.2%	+10.6%	+11.6%	-24.9%	-20.2%